1 year return (CAGR)
-85.49%
InVivo Therapeutics Holdings Corp Exchange (NASDAQ, USD)
NVIV
-
-0.17 (-34.28%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-80.39%
5 year return (CAGR)
-80.38%
10 year return (CAGR)
-73.17%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
995.92K
Price/Sales
-
Ent value
-6.92M
Price/Book
0.11
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.41 |
| Daily high | 0.41 |
| Daily low | 0.30 |
| Daily Volume | 1.69M |
| 1y analyst estimate | 37.50 |
| Beta | 0.66 |
| EPS (TTM) | -2.89 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NVIV | S&P500 | |
| Current price drop from All-time high | -100.00% | -0.04% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 12 Feb 2024 | 9 Mar 2009 |
| Avg drop from high | -77.84% | -10.68% |
| Avg time to new high | 186 days | 12 days |
| Max time to new high | 2659 days | 1805 days |
News
No items found